首页> 外文期刊>Cancer biotherapy and radiopharmaceuticals >Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line
【24h】

Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line

机译:SLN-姜黄素和LDH-5-Fu对SMMC-7721肝癌细胞系的协同作用

获取原文
获取原文并翻译 | 示例
           

摘要

Curcumin and 5-Fluorouracil (5-Fu) have been reported to have anticancer potentials and show certain synergetic effect on some cancer cell lines. However, the poor bioavailability and rapid metabolism limited their medical application. In this study, we encapsulated curcumin with solid lipid nanoparticles (SLN), 5-Fu with Layered double hydroxides (LDHs) separately and tested its properties and anticancer potentials. SLN-curcumin and LDH-5-Fu were determined to be 100 and 60 nm by Transmission Electron Microscopy detection, and the loading efficiency were 28%±2.5% and 16.7%±1.8%, individually. Furthermore, SLN-curcumin and LDH-5-Fu showed a significantly synergetic effect on SMMC-7721 cell stronger than plain drugs together, of which the Idrug loaded nano-carriers was only 0.315. FACS analysis revealed that the combination of SLN-curcumin and LDH-5-Fu induced 80.1% apoptosis in SMMC-7721 cells, which were 1.7-folds of the sum of the two plain drug loaded carriers. The results demonstrated the significant synergetic anticancer potentials of nano-encapsulated curcumin and 5-Fu, which could be further explored for the treatment of other carcinoma.
机译:姜黄素和5-氟尿嘧啶(5-Fu)具有抗癌潜力,并且对某些癌细胞系具有一定的协同作用。然而,不良的生物利用度和快速的代谢限制了它们的医学应用。在这项研究中,我们分别用固体脂质纳米颗粒(SLN),5-Fu和层状双氢氧化物(LDHs)封装姜黄素,并测试了其特性和抗癌潜力。通过透射电子显微镜检测确定SLN-姜黄素和LDH-5-Fu分别为100和60nm,分别的负载效率为28%±2.5%和16.7%±1.8%。此外,SLN-姜黄素和LDH-5-Fu对SMMC-7721细胞的协同作用强于普通药物,其中载有Idrug的纳米载体仅为0.315。 FACS分析表明,SLN-姜黄素和LDH-5-Fu的组合在SMMC-7721细胞中诱导了80.1%的细胞凋亡,是两种载有普通药物的载体总和的1.7倍。结果表明,纳米囊包姜黄素和5-Fu具有显着的协同抗癌潜力,可进一步用于治疗其他癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号